Mykaela Wagner

Scientist at NeuBase Therapeutics - Pittsburgh, PA, US

Mykaela Wagner's Colleagues at NeuBase Therapeutics
Diane Carlisle

Scientific Consultant for Huntington's Disease Preclinical Development

Contact Diane Carlisle

Ranajoy Sarkar

Vice President, Head of Business Development (Nasdaq: NBSE)

Contact Ranajoy Sarkar

View All Mykaela Wagner's Colleagues
Mykaela Wagner's Contact Details
HQ
N/A
Location
Company
NeuBase Therapeutics
Mykaela Wagner's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Mykaela Wagner
Mykaela Wagner currently works for NeuBase Therapeutics, Inc.
Mykaela Wagner's role at NeuBase Therapeutics, Inc is Scientist.
Mykaela Wagner's email address is ***@neubasetherapeutics.com. To view Mykaela Wagner's full email address, please signup to ConnectPlex.
Mykaela Wagner works in the Pharmaceuticals industry.
Mykaela Wagner's colleagues at NeuBase Therapeutics are Matthew Koch, James Burrows, Austin Kilgore, Ryan Dyer, Diane Carlisle, Ranajoy Sarkar, Natasha Bennett and others.
Mykaela Wagner's phone number is N/A
See more information about Mykaela Wagner